Published in J Biol Chem on November 04, 2010
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci (2011) 6.01
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci (2011) 5.24
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron (2013) 3.63
PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol (2011) 2.82
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.73
Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain. Nat Struct Mol Biol (2011) 2.73
Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol (2011) 2.48
TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A (2012) 1.91
Identification of RNA-protein interaction networks using PAR-CLIP. Wiley Interdiscip Rev RNA (2011) 1.61
Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer (2014) 1.56
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep (2012) 1.50
TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem (2012) 1.50
The cotranslational function of ribosome-associated Hsp70 in eukaryotic protein homeostasis. Cell (2013) 1.46
Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43
Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem (2012) 1.43
Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res (2012) 1.42
RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion (2011) 1.40
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med (2011) 1.38
Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J Biol Chem (2014) 1.37
TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res (2012) 1.35
TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements. Proc Natl Acad Sci U S A (2012) 1.33
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet (2012) 1.31
A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem (2011) 1.27
The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet (2012) 1.25
The neuropathology of chronic traumatic encephalopathy. Brain Pathol (2015) 1.24
Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol Med (2013) 1.22
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet (2013) 1.21
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol Neurodegener (2011) 1.20
Library construction for next-generation sequencing: overviews and challenges. Biotechniques (2014) 1.20
Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J (2012) 1.19
Cell biology of spinocerebellar ataxia. J Cell Biol (2012) 1.19
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet (2011) 1.18
catRAPID omics: a web server for large-scale prediction of protein-RNA interactions. Bioinformatics (2013) 1.13
Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res Ther (2014) 1.11
TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J (2011) 1.09
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2014) 1.08
Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J (2011) 1.07
Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J (2013) 1.05
Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS One (2012) 1.05
Molecular determinants of the axonal mRNA transcriptome. Dev Neurobiol (2013) 1.04
Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One (2012) 1.04
RNA-binding proteins in neurodegeneration: Seq and you shall receive. Trends Neurosci (2015) 1.03
Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum Mol Genet (2012) 1.02
Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J Biol Chem (2012) 1.02
Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet (2013) 1.02
Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegener (2012) 1.02
The role of transposable elements in health and diseases of the central nervous system. J Neurosci (2013) 1.01
Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice. Mol Neurobiol (2013) 0.98
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol (2011) 0.97
Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. PLoS One (2013) 0.97
The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol (2012) 0.95
XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats. J Neurochem (2012) 0.94
The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med (2016) 0.94
Resources for the Comprehensive Discovery of Functional RNA Elements. Mol Cell (2016) 0.92
Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J Biol Chem (2013) 0.92
A fruitful endeavor: modeling ALS in the fruit fly. Brain Res (2014) 0.91
RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA (2011) 0.90
Neurodegeneration-associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/Staufen (STAU1) and regulates SIRT1 expression in neuronal cells. J Biol Chem (2012) 0.89
MicroRNAs and the Regulation of Tau Metabolism. Int J Alzheimers Dis (2012) 0.89
Amyotrophic lateral sclerosis: an update on recent genetic insights. J Neurol (2013) 0.89
Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet (2013) 0.89
Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis Model Mech (2013) 0.88
Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc Natl Acad Sci U S A (2014) 0.88
Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq. PLoS One (2013) 0.87
The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Res (2014) 0.86
Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res (2013) 0.86
Comparison of parallel high-throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. G3 (Bethesda) (2012) 0.86
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med (2014) 0.86
TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration. Biol Chem (2012) 0.85
Astrocytic TDP-43 pathology in Alexander disease. J Neurosci (2014) 0.85
An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun (2015) 0.85
The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43. PLoS One (2013) 0.84
C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. Am J Neurodegener Dis (2014) 0.84
Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci (2014) 0.84
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.83
Profiling the genes affected by pathogenic TDP-43 in astrocytes. J Neurochem (2014) 0.83
The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities. Nucleic Acids Res (2015) 0.83
The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio (2013) 0.83
The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci (2015) 0.83
Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization. RNA (2013) 0.82
Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43). J Biol Chem (2014) 0.82
Drosophila Answers to TDP-43 Proteinopathies. J Amino Acids (2012) 0.81
Identification of 3' gene ends using transcriptional and genomic conservation across vertebrates. BMC Genomics (2012) 0.81
Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms. F1000 Biol Rep (2011) 0.81
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention. J Alzheimers Dis Parkinsonism (2013) 0.81
TDP-43 and FUS/TLS yield a target-rich haul in ALS. Nat Neurosci (2012) 0.81
Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet (2016) 0.80
Structural disorder and the loss of RNA homeostasis in aging and neurodegenerative disease. Front Genet (2013) 0.79
TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog Neurobiol (2016) 0.79
TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum Mol Genet (2015) 0.79
TLS/FUS: a protein in cancer and ALS. Cell Cycle (2012) 0.79
TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res (2015) 0.79
TDP-43 regulates β-adducin (Add2) transcript stability. RNA Biol (2014) 0.78
Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila. PLoS One (2013) 0.78
RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis. Sci Rep (2017) 0.78
TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res (2017) 0.78
Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. Brain Res (2013) 0.77
Inside out: the role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol (2016) 0.77
Dysregulated axonal RNA translation in amyotrophic lateral sclerosis. Wiley Interdiscip Rev RNA (2016) 0.77
A network of RNA and protein interactions in Fronto Temporal Dementia. Front Mol Neurosci (2015) 0.77
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res (2006) 48.10
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
The UCSC Genome Browser database: update 2010. Nucleic Acids Res (2009) 16.58
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
Characterizing gene sets with FuncAssociate. Bioinformatics (2003) 14.10
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (2009) 12.99
hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem (1993) 11.44
Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science (2008) 11.33
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
RNA regulons: coordination of post-transcriptional events. Nat Rev Genet (2007) 10.12
Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev (1999) 9.94
Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science (1995) 5.97
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet (2010) 5.75
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J (2001) 5.23
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol (1995) 5.18
Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem (2001) 4.87
RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc (2006) 4.28
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A (2009) 4.18
Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol (2000) 4.12
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci (2008) 4.01
TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem (2005) 3.99
A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron (2005) 3.93
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A (2010) 3.39
Next generation software for functional trend analysis. Bioinformatics (2009) 3.01
Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron (2006) 2.98
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A (2005) 2.90
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci (2007) 2.75
ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A (2010) 2.65
Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res (2005) 2.55
TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem (2009) 2.40
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J (2009) 2.37
Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res (2009) 2.37
Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res (2010) 2.35
TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis (2010) 2.31
TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem (2008) 1.98
Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem (2010) 1.76
Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J (2010) 1.66
Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci (2000) 1.63
Post-transcriptional operons and regulons co-ordinating gene expression. Chromosome Res (2005) 1.57
RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol (2007) 1.57
SnapShot: The splicing regulatory machinery. Cell (2008) 1.45
Effect of dynamic exclusion duration on spectral count based quantitative proteomics. Anal Chem (2009) 1.44
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J Neurol Sci (2009) 1.30
Genome-wide functional analysis of human 5' untranslated region introns. Genome Biol (2010) 1.14
TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons. J Struct Biol (2009) 1.11
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol (2010) 1.06
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc (2010) 22.66
Global mapping of the yeast genetic interaction network. Science (2004) 21.34
The genetic landscape of a cell. Science (2010) 16.52
A map of the interactome network of the metazoan C. elegans. Science (2004) 15.60
Characterizing gene sets with FuncAssociate. Bioinformatics (2003) 14.10
Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature (2004) 13.27
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00
High-quality binary protein interaction map of the yeast interactome network. Science (2008) 10.65
Pre-mRNA splicing: awash in a sea of proteins. Mol Cell (2003) 8.28
Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11
An empirical framework for binary interactome mapping. Nat Methods (2008) 6.59
Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell (2009) 6.16
An experimentally derived confidence score for binary protein-protein interactions. Nat Methods (2008) 5.27
Quantitative phenotyping via deep barcode sequencing. Genome Res (2009) 5.13
A critical assessment of Mus musculus gene function prediction using integrated genomic evidence. Genome Biol (2008) 4.78
Nicastrin functions as a gamma-secretase-substrate receptor. Cell (2005) 4.64
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions. Nat Genet (2007) 4.59
Assessing experimentally derived interactions in a small world. Proc Natl Acad Sci U S A (2003) 4.53
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature (2012) 4.35
Literature-curated protein interaction datasets. Nat Methods (2009) 4.21
Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell (2006) 4.10
LRP: role in vascular wall integrity and protection from atherosclerosis. Science (2003) 3.89
Independently evolved virulence effectors converge onto hubs in a plant immune system network. Science (2011) 3.72
Defining genetic interaction. Proc Natl Acad Sci U S A (2008) 3.67
Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol (2007) 3.65
Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis. Nature (2005) 3.62
Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA (2002) 3.57
Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics (2006) 3.56
Predicting gene function from patterns of annotation. Genome Res (2003) 3.55
Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell (2012) 3.50
How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci (2003) 3.47
Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? Trends Mol Med (2004) 3.44
Intensity-based protein identification by machine learning from a library of tandem mass spectra. Nat Biotechnol (2004) 3.30
Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron (2005) 3.25
Functional specificity among ribosomal proteins regulates gene expression. Cell (2007) 3.22
A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity. Genes Dev (2008) 3.19
Combining biological networks to predict genetic interactions. Proc Natl Acad Sci U S A (2004) 3.18
Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation (2005) 3.16
Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev (2004) 3.13
Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics (2007) 3.09
Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A (2002) 3.03
Next generation software for functional trend analysis. Bioinformatics (2009) 3.01
Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron (2008) 3.01
MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells (2010) 2.89
A long noncoding RNA mediates both activation and repression of immune response genes. Science (2013) 2.85
The ever-increasing complexities of the exon junction complex. Curr Opin Cell Biol (2004) 2.85
A quantitative analysis of intron effects on mammalian gene expression. RNA (2003) 2.80
High-detectivity polymer photodetectors with spectral response from 300 nm to 1450 nm. Science (2009) 2.78
Judging the quality of gene expression-based clustering methods using gene annotation. Genome Res (2002) 2.76
The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci (2008) 2.73
The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression. Cell (2007) 2.72
Motifs, themes and thematic maps of an integrated Saccharomyces cerevisiae interaction network. J Biol (2005) 2.68
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem (2002) 2.67
Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron (2007) 2.55
Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature (2008) 2.51
Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods (2009) 2.50
Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest (2008) 2.46
TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem (2009) 2.40
eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nat Struct Mol Biol (2004) 2.38
Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell (2008) 2.35
Reelin activates SRC family tyrosine kinases in neurons. Curr Biol (2003) 2.29
Ordered and dynamic assembly of single spliceosomes. Science (2011) 2.27
A convergence of rRNA and mRNA quality control pathways revealed by mechanistic analysis of nonfunctional rRNA decay. Mol Cell (2009) 2.26
Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. J Biol Chem (2005) 2.24
A protein domain-based interactome network for C. elegans early embryogenesis. Cell (2008) 2.23
An ancient transcription factor initiates the burst of piRNA production during early meiosis in mouse testes. Mol Cell (2013) 2.23
Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal Chem (2002) 2.22
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron (2003) 2.19
The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stress. Mol Cell (2002) 2.10
The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem (2008) 2.09
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature (2012) 2.08
Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol (2007) 2.07
Next-generation sequencing to generate interactome datasets. Nat Methods (2011) 2.06
Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci (2004) 2.04
C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science (2009) 2.04
Isoform discovery by targeted cloning, 'deep-well' pooling and parallel sequencing. Nat Methods (2008) 2.03
Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell (2010) 2.02
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.01
Predicting co-complexed protein pairs using genomic and proteomic data integration. BMC Bioinformatics (2004) 2.00
Metabolic signatures of exercise in human plasma. Sci Transl Med (2010) 1.99
5' exon interactions within the human spliceosome establish a framework for exon junction complex structure and assembly. Genes Dev (2002) 1.98
Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA (2005) 1.96
Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants. Nat Genet (2006) 1.92
Systematic exploration of synergistic drug pairs. Mol Syst Biol (2011) 1.89
The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. Cell (2012) 1.88
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J Biol Chem (2011) 1.88
Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem (2002) 1.88
Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J Biol Chem (2008) 1.83
Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem (2002) 1.83
Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol (2004) 1.81
Chipper: discovering transcription-factor targets from chromatin immunoprecipitation microarrays using variance stabilization. Genome Biol (2005) 1.80
Regulating general mutation rates: examination of the hypermutable state model for Cairnsian adaptive mutation. Genetics (2003) 1.80